<?xml version="1.0" encoding="UTF-8"?>
<ref id="B20">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Batist</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>J. H.</given-names>
   </name>
   <name>
    <surname>Spatz</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Miller</surname>
    <given-names>W. H.</given-names>
   </name>
   <name>
    <surname>Cocolakis</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Rousseau</surname>
    <given-names>C.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2011</year>). 
  <article-title>Resistance to cancer treatment: the role of somatic genetic events and the challenges for targeted therapies</article-title>. 
  <source>Front. Pharmacol.</source>
  <volume>2</volume>:
  <fpage>59</fpage>. 
  <pub-id pub-id-type="doi">10.3389/fphar.2011.00059</pub-id>
  <?supplied-pmid 22007174?>
  <pub-id pub-id-type="pmid">22007174</pub-id>
 </mixed-citation>
</ref>
